

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 5.40846629 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.14825003 |
| 3 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.78188050 |
| 4 | microglial cell activation (GO:0001774) | 4.31105431 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.15411264 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.15411264 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.15411264 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.15411264 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.15411264 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.15411264 |
| 11 | neutrophil mediated immunity (GO:0002446) | 4.11014762 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.07858111 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.03769781 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.03769781 |
| 15 | regulation of activation of Janus kinase activity (GO:0010533) | 4.03252785 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00784882 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.94771879 |
| 18 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.90553564 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80342701 |
| 20 | phospholipid homeostasis (GO:0055091) | 3.78014354 |
| 21 | cellular extravasation (GO:0045123) | 3.75359378 |
| 22 | neutrophil activation (GO:0042119) | 3.75194623 |
| 23 | myeloid leukocyte mediated immunity (GO:0002444) | 3.72454701 |
| 24 | dopamine transport (GO:0015872) | 3.72343285 |
| 25 | macrophage activation (GO:0042116) | 3.66785746 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.59516246 |
| 27 | cellular response to epinephrine stimulus (GO:0071872) | 3.59429298 |
| 28 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.57719184 |
| 29 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.53407540 |
| 30 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.53407540 |
| 31 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.51697276 |
| 32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.45785949 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.44681333 |
| 34 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.40134258 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.39040634 |
| 36 | cellular response to catecholamine stimulus (GO:0071870) | 3.36117923 |
| 37 | cellular response to monoamine stimulus (GO:0071868) | 3.36117923 |
| 38 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.26165739 |
| 39 | hepatocyte apoptotic process (GO:0097284) | 3.23836663 |
| 40 | granulocyte activation (GO:0036230) | 3.22088009 |
| 41 | dendritic cell migration (GO:0036336) | 3.21584069 |
| 42 | response to interleukin-15 (GO:0070672) | 3.18514680 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.18295929 |
| 44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.14856473 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.14404201 |
| 46 | response to epinephrine (GO:0071871) | 3.12133767 |
| 47 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.99629513 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.99629513 |
| 49 | dendritic cell chemotaxis (GO:0002407) | 2.98654101 |
| 50 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.98017864 |
| 51 | negative regulation of B cell mediated immunity (GO:0002713) | 2.98017864 |
| 52 | regulation of T cell chemotaxis (GO:0010819) | 2.96344535 |
| 53 | positive regulation of T cell chemotaxis (GO:0010820) | 2.96344535 |
| 54 | response to monoamine (GO:0071867) | 2.94268171 |
| 55 | response to catecholamine (GO:0071869) | 2.94268171 |
| 56 | regulation of memory T cell differentiation (GO:0043380) | 2.88210313 |
| 57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87450886 |
| 58 | regulation of necroptotic process (GO:0060544) | 2.87395976 |
| 59 | catecholamine transport (GO:0051937) | 2.86523023 |
| 60 | activated T cell proliferation (GO:0050798) | 2.85585848 |
| 61 | negative T cell selection (GO:0043383) | 2.84396249 |
| 62 | detection of biotic stimulus (GO:0009595) | 2.83984897 |
| 63 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.82365207 |
| 64 | regulation of beta-amyloid formation (GO:1902003) | 2.80630548 |
| 65 | negative regulation of B cell proliferation (GO:0030889) | 2.78523960 |
| 66 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.76308107 |
| 67 | macroautophagy (GO:0016236) | 2.76133997 |
| 68 | negative thymic T cell selection (GO:0045060) | 2.73605145 |
| 69 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.70243152 |
| 70 | negative regulation of protein autophosphorylation (GO:0031953) | 2.69715138 |
| 71 | histone H3-K36 demethylation (GO:0070544) | 2.69391064 |
| 72 | iron ion import (GO:0097286) | 2.68862922 |
| 73 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.68481714 |
| 74 | positive T cell selection (GO:0043368) | 2.67713361 |
| 75 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.66918062 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66619747 |
| 77 | response to host immune response (GO:0052572) | 2.66619747 |
| 78 | cellular response to ethanol (GO:0071361) | 2.65540895 |
| 79 | positive regulation of granulocyte differentiation (GO:0030854) | 2.64884443 |
| 80 | peristalsis (GO:0030432) | 2.64876446 |
| 81 | interkinetic nuclear migration (GO:0022027) | 2.64479791 |
| 82 | cardiac muscle hypertrophy (GO:0003300) | 2.64424631 |
| 83 | T-helper 1 type immune response (GO:0042088) | 2.62404615 |
| 84 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.62160085 |
| 85 | import into cell (GO:0098657) | 2.62067730 |
| 86 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.61840550 |
| 87 | negative regulation of complement activation (GO:0045916) | 2.60706436 |
| 88 | negative regulation of myotube differentiation (GO:0010832) | 2.60505359 |
| 89 | regulation of regulatory T cell differentiation (GO:0045589) | 2.59797904 |
| 90 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.59494815 |
| 91 | cellular response to interleukin-15 (GO:0071350) | 2.59238853 |
| 92 | detection of other organism (GO:0098543) | 2.57138401 |
| 93 | cytidine deamination (GO:0009972) | 2.56014331 |
| 94 | cytidine metabolic process (GO:0046087) | 2.56014331 |
| 95 | cytidine catabolic process (GO:0006216) | 2.56014331 |
| 96 | positive regulation of tolerance induction (GO:0002645) | 2.55963094 |
| 97 | establishment of protein localization to Golgi (GO:0072600) | 2.55878811 |
| 98 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.54526774 |
| 99 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.53495844 |
| 100 | positive thymic T cell selection (GO:0045059) | 2.53272381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.61633786 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34548886 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.27048997 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.22015330 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.06654046 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.95324570 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.88167456 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69669587 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39816143 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.27282213 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22938291 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.14743435 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.08688469 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06374302 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.06019099 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.03770732 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88002139 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85600453 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83432336 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80775491 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.80503932 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79522161 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.71360713 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62646222 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60085602 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.58583872 |
| 27 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55695579 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55329008 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52991413 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52572516 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47904595 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46794535 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41055253 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40904467 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40078316 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.39066958 |
| 37 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30174072 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29765927 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27609023 |
| 40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26924552 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26407376 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.24687018 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24436087 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.23421178 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22594145 |
| 46 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20983341 |
| 47 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20081603 |
| 48 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20038368 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19702680 |
| 50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19349030 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18186709 |
| 52 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17335426 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16965879 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16645086 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15901484 |
| 56 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11838031 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11719852 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11665790 |
| 59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09034427 |
| 60 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08002440 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06203595 |
| 62 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05605252 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05436376 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04505597 |
| 65 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04283787 |
| 66 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03993218 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03629740 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03374326 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03076827 |
| 70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02783339 |
| 71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02267827 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01179206 |
| 73 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00837452 |
| 74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00014930 |
| 75 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99846889 |
| 76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99789986 |
| 77 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.99396499 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99346593 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99050384 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98209582 |
| 81 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96612783 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96479674 |
| 83 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96387512 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95604424 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95348336 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95139910 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94708367 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94131685 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92494129 |
| 90 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.92239605 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91771054 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91771054 |
| 93 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91241902 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91241902 |
| 95 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.89767924 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89264268 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89028293 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88350805 |
| 99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87967760 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87167999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 5.08659206 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.43231829 |
| 3 | MP0003724_increased_susceptibility_to | 4.29614247 |
| 4 | MP0003880_abnormal_central_pattern | 3.67483938 |
| 5 | MP0008260_abnormal_autophagy | 3.61938204 |
| 6 | MP0003646_muscle_fatigue | 3.46080718 |
| 7 | MP0002332_abnormal_exercise_endurance | 2.76435292 |
| 8 | MP0003221_abnormal_cardiomyocyte_apopto | 2.64592610 |
| 9 | MP0004381_abnormal_hair_follicle | 2.55447831 |
| 10 | MP0003303_peritoneal_inflammation | 2.54292852 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.16832083 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.14450519 |
| 13 | MP0003950_abnormal_plasma_membrane | 2.13636502 |
| 14 | MP0004484_altered_response_of | 2.10985443 |
| 15 | MP0004130_abnormal_muscle_cell | 1.98493829 |
| 16 | MP0003195_calcinosis | 1.97101005 |
| 17 | MP0001800_abnormal_humoral_immune | 1.80198210 |
| 18 | MP0000749_muscle_degeneration | 1.71731642 |
| 19 | MP0002419_abnormal_innate_immunity | 1.70447482 |
| 20 | MP0002277_abnormal_respiratory_mucosa | 1.69802605 |
| 21 | MP0003828_pulmonary_edema | 1.69735047 |
| 22 | MP0005174_abnormal_tail_pigmentation | 1.67798836 |
| 23 | MP0003763_abnormal_thymus_physiology | 1.64384862 |
| 24 | MP0008057_abnormal_DNA_replication | 1.63824091 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.60328899 |
| 26 | MP0004883_abnormal_blood_vessel | 1.59691628 |
| 27 | MP0000015_abnormal_ear_pigmentation | 1.56804186 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.53028318 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.51214714 |
| 30 | MP0002723_abnormal_immune_serum | 1.50219325 |
| 31 | MP0005671_abnormal_response_to | 1.49934497 |
| 32 | MP0003436_decreased_susceptibility_to | 1.49722865 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.43998289 |
| 34 | MP0003787_abnormal_imprinting | 1.42903210 |
| 35 | MP0000685_abnormal_immune_system | 1.41509418 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.41336170 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.37815378 |
| 38 | MP0001819_abnormal_immune_cell | 1.34473823 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.33951994 |
| 40 | MP0003011_delayed_dark_adaptation | 1.33614120 |
| 41 | MP0008877_abnormal_DNA_methylation | 1.32982701 |
| 42 | MP0005025_abnormal_response_to | 1.32329159 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.30004658 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.28874584 |
| 45 | MP0009785_altered_susceptibility_to | 1.28755370 |
| 46 | MP0003045_fibrosis | 1.28657616 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.28579283 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.27688133 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.24701713 |
| 50 | MP0004036_abnormal_muscle_relaxation | 1.24629216 |
| 51 | MP0006082_CNS_inflammation | 1.23781828 |
| 52 | MP0004510_myositis | 1.22160381 |
| 53 | MP0001958_emphysema | 1.21257042 |
| 54 | MP0001790_abnormal_immune_system | 1.17986455 |
| 55 | MP0005387_immune_system_phenotype | 1.17986455 |
| 56 | MP0005164_abnormal_response_to | 1.14581042 |
| 57 | MP0002102_abnormal_ear_morphology | 1.12243484 |
| 58 | MP0000427_abnormal_hair_cycle | 1.11596938 |
| 59 | MP0002398_abnormal_bone_marrow | 1.11570750 |
| 60 | MP0005620_abnormal_muscle_contractility | 1.10648332 |
| 61 | MP0000716_abnormal_immune_system | 1.09983411 |
| 62 | MP0003690_abnormal_glial_cell | 1.09926842 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.07535184 |
| 64 | MP0006138_congestive_heart_failure | 1.05545161 |
| 65 | MP0002909_abnormal_adrenal_gland | 0.99772520 |
| 66 | MP0005266_abnormal_metabolism | 0.97988739 |
| 67 | MP0001545_abnormal_hematopoietic_system | 0.97518521 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.97518521 |
| 69 | MP0006054_spinal_hemorrhage | 0.96804497 |
| 70 | MP0009764_decreased_sensitivity_to | 0.96197758 |
| 71 | MP0002405_respiratory_system_inflammati | 0.95994483 |
| 72 | MP0002722_abnormal_immune_system | 0.93175797 |
| 73 | MP0005464_abnormal_platelet_physiology | 0.93167207 |
| 74 | MP0000689_abnormal_spleen_morphology | 0.92330538 |
| 75 | MP0001533_abnormal_skeleton_physiology | 0.91386506 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.89425841 |
| 77 | MP0002106_abnormal_muscle_physiology | 0.88332923 |
| 78 | MP0003866_abnormal_defecation | 0.86838889 |
| 79 | MP0000751_myopathy | 0.85450427 |
| 80 | MP0002006_tumorigenesis | 0.85301110 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.84870149 |
| 82 | MP0000703_abnormal_thymus_morphology | 0.84785468 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 0.83258489 |
| 84 | MP0004947_skin_inflammation | 0.80790138 |
| 85 | MP0008004_abnormal_stomach_pH | 0.77568865 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 0.76624177 |
| 87 | MP0002429_abnormal_blood_cell | 0.76613471 |
| 88 | MP0000371_diluted_coat_color | 0.76079155 |
| 89 | MP0002132_abnormal_respiratory_system | 0.76012518 |
| 90 | MP0002971_abnormal_brown_adipose | 0.75456431 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.74741498 |
| 92 | MP0002009_preneoplasia | 0.73166143 |
| 93 | MP0004084_abnormal_cardiac_muscle | 0.72514847 |
| 94 | MP0000249_abnormal_blood_vessel | 0.71631134 |
| 95 | MP0002972_abnormal_cardiac_muscle | 0.71202841 |
| 96 | MP0002168_other_aberrant_phenotype | 0.70174617 |
| 97 | MP0005310_abnormal_salivary_gland | 0.69626481 |
| 98 | MP0003091_abnormal_cell_migration | 0.68774651 |
| 99 | MP0009763_increased_sensitivity_to | 0.68740987 |
| 100 | MP0005375_adipose_tissue_phenotype | 0.68685096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.17867048 |
| 2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 5.12563760 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.91431186 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.64876730 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.52005031 |
| 6 | Optic neuritis (HP:0100653) | 4.52005031 |
| 7 | Orchitis (HP:0100796) | 4.24857042 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.17377092 |
| 9 | Myositis (HP:0100614) | 4.04157195 |
| 10 | Difficulty running (HP:0009046) | 4.02071823 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.82252648 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.72701304 |
| 13 | Nemaline bodies (HP:0003798) | 3.69426556 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 3.57813714 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.55522722 |
| 16 | Fibular aplasia (HP:0002990) | 3.52532578 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.51719142 |
| 18 | Peritonitis (HP:0002586) | 3.38066868 |
| 19 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.32222186 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.31982968 |
| 21 | Gingivitis (HP:0000230) | 3.27697626 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.12953405 |
| 23 | Postural instability (HP:0002172) | 3.11436507 |
| 24 | Exercise-induced myalgia (HP:0003738) | 3.10928907 |
| 25 | Keratoconjunctivitis (HP:0001096) | 2.99921403 |
| 26 | Spontaneous hematomas (HP:0007420) | 2.94781924 |
| 27 | Abnormal finger flexion creases (HP:0006143) | 2.80923395 |
| 28 | Oligodactyly (hands) (HP:0001180) | 2.79243290 |
| 29 | Muscle fiber splitting (HP:0003555) | 2.79045901 |
| 30 | Hypoplastic iliac wings (HP:0002866) | 2.78411056 |
| 31 | Recurrent skin infections (HP:0001581) | 2.72595263 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.68753515 |
| 33 | Hyperkalemia (HP:0002153) | 2.67827600 |
| 34 | Abnormality of T cells (HP:0002843) | 2.59043814 |
| 35 | Chest pain (HP:0100749) | 2.56908201 |
| 36 | Leukocytosis (HP:0001974) | 2.56461865 |
| 37 | Subacute progressive viral hepatitis (HP:0006572) | 2.56279145 |
| 38 | Gingival bleeding (HP:0000225) | 2.56038550 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 2.54078099 |
| 40 | Adactyly (HP:0009776) | 2.53337314 |
| 41 | Facial diplegia (HP:0001349) | 2.49306544 |
| 42 | Increased connective tissue (HP:0009025) | 2.48027248 |
| 43 | Broad ribs (HP:0000885) | 2.47463812 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.44899569 |
| 45 | Arterial thrombosis (HP:0004420) | 2.44390398 |
| 46 | Eosinophilia (HP:0001880) | 2.39749150 |
| 47 | Stomatitis (HP:0010280) | 2.38951239 |
| 48 | Hemiplegia (HP:0002301) | 2.36747313 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36344007 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36344007 |
| 51 | Radial bowing (HP:0002986) | 2.33400005 |
| 52 | Hemoptysis (HP:0002105) | 2.32914535 |
| 53 | Hypoplastic pelvis (HP:0008839) | 2.30544583 |
| 54 | Recurrent bronchitis (HP:0002837) | 2.29506348 |
| 55 | Encephalitis (HP:0002383) | 2.29121998 |
| 56 | Recurrent viral infections (HP:0004429) | 2.22163823 |
| 57 | Hyporeflexia of lower limbs (HP:0002600) | 2.21847752 |
| 58 | Keratitis (HP:0000491) | 2.21565953 |
| 59 | Abnormality of eosinophils (HP:0001879) | 2.20658099 |
| 60 | Narrow palate (HP:0000189) | 2.17925362 |
| 61 | Autoimmune hemolytic anemia (HP:0001890) | 2.15365529 |
| 62 | Hypoplastic nipples (HP:0002557) | 2.14043313 |
| 63 | Increased CSF protein (HP:0002922) | 2.13912515 |
| 64 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.12213473 |
| 65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10399086 |
| 66 | Abnormality of the pubic bones (HP:0003172) | 2.08030040 |
| 67 | Myocardial infarction (HP:0001658) | 2.04965768 |
| 68 | Subaortic stenosis (HP:0001682) | 2.03292935 |
| 69 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.03292935 |
| 70 | Meningitis (HP:0001287) | 1.97698335 |
| 71 | EMG: myopathic abnormalities (HP:0003458) | 1.96851924 |
| 72 | Hematochezia (HP:0002573) | 1.96506663 |
| 73 | Split foot (HP:0001839) | 1.95487302 |
| 74 | Slow saccadic eye movements (HP:0000514) | 1.94026796 |
| 75 | Pelvic girdle muscle weakness (HP:0003749) | 1.91987669 |
| 76 | Foot dorsiflexor weakness (HP:0009027) | 1.91235294 |
| 77 | Papillary thyroid carcinoma (HP:0002895) | 1.89366653 |
| 78 | Thyroiditis (HP:0100646) | 1.88616460 |
| 79 | Urticaria (HP:0001025) | 1.88105767 |
| 80 | Neurodegeneration (HP:0002180) | 1.87270134 |
| 81 | Aortic aneurysm (HP:0004942) | 1.86154005 |
| 82 | Exercise-induced muscle cramps (HP:0003710) | 1.85658318 |
| 83 | Amyloidosis (HP:0011034) | 1.85643194 |
| 84 | Long clavicles (HP:0000890) | 1.84383642 |
| 85 | Conjunctival telangiectasia (HP:0000524) | 1.83206184 |
| 86 | Periodontitis (HP:0000704) | 1.82852994 |
| 87 | Acute hepatic failure (HP:0006554) | 1.81706879 |
| 88 | Anorexia (HP:0002039) | 1.81695354 |
| 89 | Pulmonary embolism (HP:0002204) | 1.80963363 |
| 90 | Episodic fever (HP:0001954) | 1.80096211 |
| 91 | Granulocytopenia (HP:0001913) | 1.79221036 |
| 92 | Abnormality of the endocardium (HP:0004306) | 1.78624797 |
| 93 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.77009465 |
| 94 | Skull defect (HP:0001362) | 1.76692980 |
| 95 | Increased variability in muscle fiber diameter (HP:0003557) | 1.75608720 |
| 96 | Calf muscle hypertrophy (HP:0008981) | 1.74449585 |
| 97 | Vasculitis (HP:0002633) | 1.74251594 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73762211 |
| 99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.71798720 |
| 100 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.71332519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 3.25801670 |
| 2 | BLK | 3.04239338 |
| 3 | RIPK4 | 2.58942243 |
| 4 | TIE1 | 2.53393279 |
| 5 | CSK | 2.40416844 |
| 6 | FRK | 2.38146994 |
| 7 | FES | 2.21754607 |
| 8 | PIK3CG | 2.11269212 |
| 9 | TNIK | 2.06840624 |
| 10 | IRAK4 | 2.05391778 |
| 11 | IKBKE | 2.03413170 |
| 12 | AKT3 | 1.96254135 |
| 13 | MAP3K7 | 1.92344959 |
| 14 | TAOK3 | 1.92107654 |
| 15 | GRK6 | 1.89022512 |
| 16 | MAP2K3 | 1.86886251 |
| 17 | DAPK2 | 1.83030645 |
| 18 | PTK2B | 1.75734756 |
| 19 | MAP3K6 | 1.69696471 |
| 20 | SGK2 | 1.69056742 |
| 21 | IRAK1 | 1.68536209 |
| 22 | TYK2 | 1.65970530 |
| 23 | WNK1 | 1.64224450 |
| 24 | EPHB1 | 1.63211186 |
| 25 | FGR | 1.61363955 |
| 26 | MAP3K14 | 1.59197413 |
| 27 | BMPR2 | 1.56429063 |
| 28 | MAP3K13 | 1.52141007 |
| 29 | NLK | 1.46847828 |
| 30 | PIM1 | 1.45673047 |
| 31 | JAK3 | 1.40959686 |
| 32 | TTN | 1.38211041 |
| 33 | EPHA3 | 1.35007662 |
| 34 | TXK | 1.28485478 |
| 35 | JAK1 | 1.23698452 |
| 36 | SGK3 | 1.20520370 |
| 37 | MARK2 | 1.13981790 |
| 38 | SYK | 1.11523663 |
| 39 | YES1 | 1.10418599 |
| 40 | TRPM7 | 1.09534863 |
| 41 | LATS1 | 1.07197083 |
| 42 | FGFR3 | 1.06274651 |
| 43 | PRKAA2 | 1.04457218 |
| 44 | ERBB2 | 1.04133677 |
| 45 | STK4 | 1.02773124 |
| 46 | JAK2 | 0.99063627 |
| 47 | MAP3K2 | 0.97983201 |
| 48 | TEC | 0.97925343 |
| 49 | HCK | 0.97426251 |
| 50 | MAP3K11 | 0.96518607 |
| 51 | TGFBR2 | 0.96391233 |
| 52 | STK24 | 0.91760831 |
| 53 | IRAK2 | 0.91697932 |
| 54 | ZAP70 | 0.91553733 |
| 55 | SGK223 | 0.90850192 |
| 56 | SGK494 | 0.90850192 |
| 57 | LCK | 0.90586611 |
| 58 | NEK9 | 0.89484127 |
| 59 | CHUK | 0.89178671 |
| 60 | CAMK4 | 0.85285773 |
| 61 | ACVR1B | 0.85168418 |
| 62 | IKBKB | 0.82817031 |
| 63 | GRK5 | 0.81835896 |
| 64 | MAP4K1 | 0.80958889 |
| 65 | CAMKK2 | 0.80923281 |
| 66 | CAMK1D | 0.79102477 |
| 67 | MATK | 0.78111432 |
| 68 | BTK | 0.74046259 |
| 69 | BMPR1B | 0.70262143 |
| 70 | DMPK | 0.70193657 |
| 71 | LYN | 0.68888371 |
| 72 | MAP2K4 | 0.68675427 |
| 73 | PHKG1 | 0.66352745 |
| 74 | PHKG2 | 0.66352745 |
| 75 | SGK1 | 0.65893657 |
| 76 | MAP3K1 | 0.65083191 |
| 77 | MARK3 | 0.62664998 |
| 78 | STK11 | 0.61493615 |
| 79 | MAPK12 | 0.61360313 |
| 80 | ITK | 0.60539483 |
| 81 | TBK1 | 0.60513875 |
| 82 | PDGFRB | 0.60028668 |
| 83 | CAMK1 | 0.59234267 |
| 84 | PINK1 | 0.54344944 |
| 85 | KIT | 0.51601818 |
| 86 | MAP3K3 | 0.51299106 |
| 87 | ADRBK1 | 0.50596246 |
| 88 | CAMK1G | 0.47954649 |
| 89 | KSR1 | 0.47456885 |
| 90 | PRKCQ | 0.47356589 |
| 91 | STK38 | 0.46737278 |
| 92 | EGFR | 0.44164176 |
| 93 | RPS6KB1 | 0.44136942 |
| 94 | GRK1 | 0.44072542 |
| 95 | PLK2 | 0.42545586 |
| 96 | TAOK1 | 0.42527183 |
| 97 | PRKCZ | 0.41970796 |
| 98 | PAK3 | 0.40931284 |
| 99 | RAF1 | 0.40852822 |
| 100 | FER | 0.40198995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26481858 |
| 2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.13065683 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98916770 |
| 4 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.94015009 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.88746198 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76098051 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74612430 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73671094 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70608339 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 1.69206277 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.69181840 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66899712 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65725700 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.62836539 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58773713 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55677504 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.51513319 |
| 18 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.48087690 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46634468 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39798675 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.39615793 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.36728620 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35668491 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33354830 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.33289284 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.33204534 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.31811371 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.22383259 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21112785 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19612863 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.18906379 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.15347968 |
| 33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12185084 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.11894542 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08954233 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05963621 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05170465 |
| 38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03555258 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.02594251 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01978626 |
| 41 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01444147 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00852629 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99344449 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97221350 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.96139105 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95968456 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93856775 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93322263 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93019860 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90292333 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87580116 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85996267 |
| 53 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85882399 |
| 54 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85655911 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85508727 |
| 56 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85414367 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85187639 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84640402 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84613205 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84422625 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83427550 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.83384445 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80091771 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79696430 |
| 65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77583707 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75818260 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75519864 |
| 68 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73909084 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73255409 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72847032 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70288084 |
| 72 | Prostate cancer_Homo sapiens_hsa05215 | 0.69760239 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.67923295 |
| 74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67840311 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67613663 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65601728 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61648982 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61123553 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60540028 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.59960611 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58812665 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58705451 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57843737 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57350958 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.57086170 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55901812 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55764312 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54345940 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52010483 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51664828 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51493553 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51433385 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50661259 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50387190 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.49490133 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49327738 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49201821 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48429374 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.47554755 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46938830 |

